Patents
Patents for C07K 2 - Peptides of undefined number of amino acids; Derivatives thereof (4,723)
04/2010
04/08/2010US20100087621 Immune reactivity to her-2/neu protein for diagnosis and treatment of malignancies in which the her-2/neu oncogene is associated
04/08/2010US20100086985 Nucleic acid and corresponding protein entitled 205p1b5 useful in treatment and detection of cancer
04/08/2010US20100086957 Method for monitoring intracellular tyrosine phosphatase activity
04/08/2010US20100086538 Antibody Molecules Which Bind to Human IL-17
04/07/2010EP2170267A1 Cationic peptide for delivering an agent into a cell
04/06/2010US7691965 Helical synthetic peptides that stimulate cellular cholesterol efflux
04/06/2010US7691962 Chemical linkers and conjugates thereof
04/06/2010US7691385 Polypeptides encoded by polynucleotides that are useful for detecting resistance to streptogramin A or to streptogramin B and related compounds
04/01/2010WO2009149339A3 P53 activator peptides
04/01/2010US20100081211 Luminescent lanthanide labelling reagents and their use
04/01/2010US20100081147 Human catechol-o-methyltransferase (comt) assay
04/01/2010US20100080813 Neutralizing anti-influenza a virus antibodies and uses thereof
03/2010
03/25/2010US20100075393 Aqueous microfabrication of functional bioelectronic architectures
03/25/2010US20100075348 Method for diagnosis of a disease involving an anti-endothelin-receptor antibody
03/25/2010US20100075297 Photosensitive polypeptide and methods of their production and use
03/25/2010US20100074923 Purification of bacterial antigens
03/25/2010US20100074887 Methods for Treating and Diagnosing Fibrotic and Fibroproliferative Diseases
03/24/2010CN101676297A Preparation method of sea cucumber active polypeptide under ultrasonic extraction
03/24/2010CN100595208C Production of sulfating fibroin protein and its use in anticoagulant
03/24/2010CN100595207C Method for continuous extraction in casein producing waste water by using film filtration
03/24/2010CN100595205C Method for preparing high viscosity hydrochloric acid casein
03/18/2010US20100069606 Tubular nanostructure targeted to cell membrane
03/18/2010US20100069571 Thioester-Terminated Water Soluble Polymers and Method of Modifying the N-Terminus of a Polypeptide Therewith
03/18/2010US20100069297 Selective Inhibition of TLR4 Signaling
03/18/2010US20100069288 Use of cysteine-rich whey derived protein in patients receiving chemotherapy or radiotherapy to improve patient survival
03/18/2010US20100068819 Compounds and methods for double labelling of polypeptides to allow multiplexing in mass spectrometric analysis
03/18/2010US20100068802 Novel human androgen receptor alternative splice variants as biomarkers and therapeutic targets
03/18/2010US20100068736 Novel Nucleotide and Amino Acid Sequences, and Assays and Methods of Use Thereof for Diagnosis of Lung Cancer
03/18/2010US20100068340 Ice-structuring peptides of lactic origin
03/18/2010US20100068228 Inducing Cellular Immune Responses to Hepatitis B Virus Using Peptide and Nucleic Acid Compositions
03/18/2010US20100068139 Methods of radiofluorination of biologically active vectors
03/17/2010CN100594215C Extraction method for dephenolize cotton seed protein
03/16/2010US7678883 for the generation of insoluble fusion peptides; used for the expression and recovery of any bioactive peptides and proteins that are recombinantly expressed
03/16/2010US7678882 Polyamino acids functionalized by at least one hydrophobic group and the therapeutic application thereof
03/11/2010WO2009018500A8 Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disorders
03/11/2010US20100062537 Polypeptide Markers for the Diagnosis and Evaluation of Pelvi-Ureteric Junction Obstruction (PUJO)
03/11/2010US20100062509 Highly porous magnetic temporary fixed bed
03/11/2010US20100062498 Polypeptide being capable of increasing the production of l-methionine, a microorganism that overexpresses said polypeptide and a process of preparing l-methionine in high yield using same
03/11/2010US20100062417 Zeolite crystals with biological material
03/11/2010US20100062028 Vaccines for malaria
03/11/2010US20100061996 Methods and compositions for modulating hepsin activation of urokinase-type plasminogen activator
03/10/2010EP2161037A2 Camptothecin-Somatostatin conjugates
03/09/2010US7674775 4-(N (S-glutathionylacetyl)amino)phenylarsenoxide (GSAO) and derivatives; antiinflammatory and antitumor agents; blood and autoimmune disorders; viral infections; anticoagulants
03/09/2010US7674752 Functional protein arrays
03/09/2010US7674470 Comprises clostridial neurotoxin light chain domains; endopeptidases; vaccines; fusion proteins; for inhibiting exocytosis
03/04/2010US20100058488 Protein formulations comprising s1-5
03/04/2010US20100056754 Nano-pump using molecular motor
03/04/2010US20100056612 Molecular entities for binding, stabilization and cellular delivery of charged molecules
03/04/2010US20100056488 Corticosteroid conjugates and uses thereof
03/04/2010US20100055706 Screening Methods for Transfusion Related Acute Lung Injury (TRALI)
03/04/2010US20100055125 Peptide Library
03/04/2010US20100055117 Allorestricted peptide-specific t cells
03/04/2010US20100055114 Use of integrin alpha 10 binding antibody to modulate extracellular matrix (cartilage) turnover
03/04/2010US20100055069 Hpv-18-based papillomavirus vaccines
03/03/2010EP1286682B1 Methods and compositions for inhibiting immunoglobulin-mediated-reperfusion injury
03/02/2010US7671176 host cells that contain an isolated nucleic acid molecule that encodes a polypeptide having mu3 opiate receptor activity; for identifying mu3 opiate receptor agonists and antagonists
03/02/2010US7671036 Positively-charged peptide nucleic acid analogs with improved properties
03/02/2010US7670826 Belonging to subfamily of human immunoglobulin superfamily; isolated antibodies and nucleic acids; transformed host cells; modulating transendothelial migration of leukocytes; inflammation, tumors
03/02/2010US7670763 determining sperm quality, and different storage media's effect thereon; male fertility
02/2010
02/25/2010WO2009118375A3 Stabilized liquid enzyme compositions
02/25/2010US20100048483 Polymeric benzyl carbonate-derivatives
02/25/2010US20100048458 Tribonectins
02/25/2010US20100048407 Method for detection of human immunodeficiency virus
02/25/2010US20100047843 Compositions and methods for enhancing the growth of mouse embryonic stem cells
02/25/2010US20100047798 Adenosine a1 and a3 receptor gene sequence variations for predicting disease outcome and treatment outcome
02/25/2010US20100047232 Modulators of neuronal regeneration
02/25/2010US20100047179 Targeted split biomolecular conjugates for the treatment of diseases, malignancies and disorders, and methods of their production
02/24/2010EP1572066B1 Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within mmp-2
02/24/2010EP1471936B1 Hiv vaccine and method of use
02/24/2010CN101657464A multivariable antigens complexed with targeting humanized monoclonal antibody
02/24/2010CN101653594A Somatostatin-dopamine chimeric analogs
02/23/2010US7666429 Nucleic acids encoding a house dust mite allergen Der P III, and uses therefor
02/23/2010US7666428 Recombinant allergen with reduced IgE binding but undiminished T-cell antigenicity
02/23/2010US7666408 Virus-like particle of an RNA bacteriophage carrier attached to an angiotensin peptide through a nonpeptide bond to form an ordered and repetitive angiotensin peptide-carrier conjugate; treating/preventing hypertension, stroke, infarction, congestive heart failure, kidney failure and retinal hemorrhage
02/18/2010US20100041867 Reversible pegylated drugs
02/18/2010US20100041866 Solid Support Reagents for Synthesis
02/18/2010US20100041827 Multilayer binding; lamellar surface structure containing at least two binding compounds is assembled under conditions in which the binding compounds self-regulate in or on the lamellar structure; organized mobile multifunctional conjugate (OMMC) assembly
02/18/2010US20100041826 Multilayer binding; lamellar surface structure containing at least two binding compounds is assembled under conditions in which the binding compounds self-regulate in or on the lamellar structure; organized mobile multifunctional conjugate (OMMC) assembly
02/18/2010US20100041092 Drug controlled molecular tags
02/18/2010US20100040643 Flavivirus immunogens and methods of use
02/18/2010US20100040634 Methods and compositions for modulating hgf/met
02/16/2010US7662910 Inhibitors for the soluble epoxide hydrolase
02/11/2010US20100037355 Sequence-determined dna fragments and corresponding polypeptides encoded thereby
02/11/2010US20100036092 Synthesis of Glatiramer Acetate
02/11/2010US20100036088 Selective poly-N-substituted glycine antibiotics
02/11/2010US20100035793 Modulators
02/11/2010US20100035260 Compositions, devices, systems, for using a Nanopore
02/09/2010US7659241 Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease
02/04/2010WO2010014236A2 Acylhydrazone-based cleavable linkers
02/04/2010US20100029902 Coated nanoparticles and method for coating nanoparticles
02/03/2010EP2148889A1 Modified plant defensin
02/02/2010US7655751 An EGFR-reactive cytotoxic T lymphocyte which recognizes a complex between the EGFR-derived peptide and human leukocyte antigen (HLA) molecule; anticarcinogenic agent
02/02/2010US7655472 compositions and methods to suppress the activation and/or proliferation of mesenchymally derived cells, as well as cells with abnormal growth characteristics; inhibit or eliminate fibrosis; cancer
02/02/2010US7655463 Treating neuropathic pain, particularly diabetic peripheral neuropathy, by administering a truncated neublastin polypeptide; activating a RET receptor tyrosine kinase
02/02/2010US7655239 Peptides for use in diagnosis, prevention and treatment of cell proliferative disorders
01/2010
01/28/2010WO2010011928A1 Methods for diagnosing and treating a heart condition in a patient
01/28/2010US20100022753 Method for modifying thiol group
01/28/2010US20100022455 Therapeutic agents comprising elastin-like peptides
01/28/2010US20100021957 Functionalized quantum dots and methods for preparing them
01/28/2010US20100021940 Method for Determining the Activity of a Protease in a Sample
1 ... 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 ... 48